Wearables/Embedded/Biosensors: An increase in the chronic disease population and shift in focus from treatment to prevention drive this technology. Continuous glucose monitors, blood pressure monitors, pulse oximeters, and electrocardiogram monitors are some of the main applications.
Smart Prosthetics/Smart Implants: These are crucial for patient management post-surgery or rehabilitation. They help in measuring the key parameters to support monitoring and early intervention to avoid readmission or complexities.
Nano-robotics/Digital Medicine: Digital pills and nanorobots are designed to monitor medicine intake to address the expensive, long-standing issue of non-adherence.
Advanced Materials/Smart Fabrics: This emerging field focuses on wound management, cardiac monitoring, and mental illness.
All these technologies and innovations are focused on providing real-time measurable value to the patient and healthcare institution. Future innovations will be aimed at mass personalization and availability.
Patient Monitoring Industry—Analysis of Investment and Trends, 2018 is part of Frost & Sullivan's global Advanced Medical Technologies Growth Partnership Service program.
About Frost & Sullivan
For over five decades, Frost & Sullivan has become world-renowned for its role in helping investors, corporate leaders and governments navigate economic changes and identify disruptive technologies, Mega Trends, new business models and companies to action, resulting in a continuous flow of growth opportunities to drive future success.
Back to HCB News
